Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue
+4.59%
EPS
+128.9%
Free cash flow
−9.03%
Total debt
−4.51%

Quarter to September 2026, against a year earlier

15.14 0.51 −3.26%
Market cap
$10.3B
P/E
30.3×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a

Avantor, Inc. (AVTR) Shares outstanding

Alert me on Shares outstanding

Avantor, Inc.'s shares outstanding at the end of fiscal 2025 was $680.6M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $680.9M. Over the past ten years it has ranged from $132.7M (fiscal 2018) to $681.9M (fiscal 2024); the current reading is higher than 90% of that period. Avantor, Inc. ranks 2nd of 47 Medical Instruments & Supplies companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $680.6M (0.19%)
FY2024 $681.9M 0.52%
FY2023 $678.4M (0.15%)
FY2022 $679.4M 13.31%
FY2021 $599.6M 2.78%
FY2020 $583.4M 45.41%
FY2019 $401.2M 202.34%
FY2018 $132.7M (12.18%)
FY2017 $151.1M (71.70%)
FY2016 $534.0M —

Quarterly newest first

Period Shares outstanding Change
Sep 2026 $680.9M 0.55%
Jun 2026 $677.2M 0.06%
Mar 2026 $676.8M (0.56%)
Dec 2025 $680.6M (0.16%)
29 more quarters

Against its own ten years

Low $132.7M High $681.9M
Ten-year median $591.5M
Current reading's percentile 90

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on AVTR